CG
IBRX icon

Cutler Group’s ImmunityBio IBRX Stock Holding History

Cutler Group’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-3,000
Closed -$10K – 4223
2022
Q4 		$10K Sell
3,000
-7,800
-72% -$42.8K ﹤0.01% 2694
2022
Q3 		$31K Buy
10,800
+4,100
+61% +$18.7K ﹤0.01% 2275
2022
Q2 		$37K Sell
6,700
-3,400
-34% -$13.7K ﹤0.01% 2178
2022
Q1 		$29K Buy
+10,100
New +$62K ﹤0.01% 2720
2021
Q2 		– Sell
-3,700
Closed -$10K – 5977
2021
Q1 		$10K Sell
3,700
-5,400
-59% -$140K ﹤0.01% 3804
2020
Q4 		$6K Sell
9,100
-1,800
-17% -$17.3K ﹤0.01% 3528
2020
Q3 		$60K Buy
10,900
+5,300
+95% +$52.8K ﹤0.01% 1675
2020
Q2 		$2K Buy
5,600
+500
+10% +$2.82K ﹤0.01% 3769
2020
Q1 		$17K Sell
5,100
-5,300
-51% -$26.5K ﹤0.01% 2404
2019
Q4 		$1K Buy
+10,400
New +$17.7K ﹤0.01% 3685
2018
Q3 		– Sell
-4,000
Closed -$18K – 4364
2018
Q2 		$18K Hold
4,000
– – ﹤0.01% 2259
2018
Q1 		$14K Buy
+4,000
New +$17.5K ﹤0.01% 2532
2017
Q4 		– Sell
-1,400
Closed -$1K – 5319
2017
Q3 		$1K Buy
+1,400
New +$8.63K ﹤0.01% 5431
2017
Q1 		– Sell
-1,500
Closed -$2K – 6727
2016
Q4 		$2K Hold
1,500
– – ﹤0.01% 5608
2016
Q3 		$2K Buy
1,500
+900
+150% +$6.72K ﹤0.01% 5703
2016
Q2 		$4K Hold
600
– – ﹤0.01% 5141
2016
Q1 		$3K Sell
600
-1,100
-65% -$10.4K ﹤0.01% 5270
2015
Q4 		$13K Buy
+1,700
New +$25.2K ﹤0.01% 3853

Other funds holding IBRX

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Cutler Group's IBRX Position: Q1 2024 in Review

Cutler Group sold out of ImmunityBio (IBRX) in Q1 2024, closing a stake of 86 shares.

Cutler Group first reported a position in IBRX in Q4 2015 and held it in 23 quarters. The position peaked at $246K in Q4 2020. 165 funds tracked by Wall St. Rank hold IBRX as of Q1 2024.

  • Cutler Group reported no remaining ImmunityBio position as of Q1 2024 after selling out during the quarter.
  • Cutler Group sold 86 ImmunityBio shares in Q1 2024.
  • Cutler Group first reported a position in ImmunityBio in Q4 2015 and held it in 23 quarters.
  • Cutler Group's ImmunityBio position peaked at $246K in Q4 2020.
  • 165 funds tracked by Wall St. Rank held ImmunityBio as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.